CompletedPhase 3ACTRN12608000160336

A prospective study of the impact upon serum electrolyte and magnesium levels of using magnesium sulfate for bowel preparation for colonoscopy.


Sponsor

Colocap Pharmaceuticals

Enrollment

100 participants

Start Date

Feb 28, 2008

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a prospective study of the impact upon serum electrolyte and magnesium levels of using magnesium sulfate for bowel preparation for colonoscopy. The study is looking for people at least 18 Yearss old, who meet criteria including: presenting for elective colonoscopy. Participants may undergo tests, treatments, or monitoring as part of the study protocol.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Colocap Balance (TM) 61.75gm magnesium sulfate, encapsulated (65 capsules). Patients will take 65 capsules orally, in batches of 5 with 250ml fluid, every 15 minutes, over a period of approximately 3

Colocap Balance (TM) 61.75gm magnesium sulfate, encapsulated (65 capsules). Patients will take 65 capsules orally, in batches of 5 with 250ml fluid, every 15 minutes, over a period of approximately 3 hours.


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000160336


Related Trials